相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Progression of Stargardt Disease Using Volumetric Hill of Vision Analyses Over 24 Months: ProgStar Report No.15
Etienne M. Schonbach et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease Phase 3 Results at 3 and 4 Years
Albert M. Maguire et al.
OPHTHALMOLOGY (2021)
The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis
Xue Wang et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline
David G. Birch et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials
Albert M. Maguire et al.
OPHTHALMOLOGY (2019)
Regional Variations and Intra-/Intersession Repeatability for Scotopic Sensitivity in Normal Controls and Patients With Inherited Retinal Degenerations
Lea D. Bennett et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration
Manjit S. Mehat et al.
OPHTHALMOLOGY (2018)
Cross-Sectional and Longitudinal Assessment of Retina Sensitivity in Patients With Childhood-Onset Stargardt Disease
Preena Tanna et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2018)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa
Lea D. Bennett et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2017)
Automated Light- and Dark-Adapted Perimetry for Evaluating Retinitis Pigmentosa: Filling a Need to Accommodate Multicenter Clinical Trials
David B. McGuigan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Improvement and Decline in Vision with Gene Therapy in Childhood Blindness
Samuel G. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Improvement in vision: a new goal for treatment of hereditary retinal degenerations
Samuel G. Jacobson et al.
EXPERT OPINION ON ORPHAN DRUGS (2015)
VFMA: Topographic Analysis of Sensitivity Data From Full-Field Static Perimetry
Richard G. Weleber et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial
Robert K. Koenekoop et al.
LANCET (2014)
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Samuel G. Jacobson et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST)
M. Klein et al.
DOCUMENTA OPHTHALMOLOGICA (2009)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success
SG Jacobson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
